Ironwood Pharmaceuticals (IRWD) Gross Profit (2013 - 2020)

Ironwood Pharmaceuticals has disclosed Gross Profit across 7 years of filings, most recently posting $115.8 million for Q4 2020.

• Gross Profit for Q4 2020 came in at $115.8 million, changed 0.43% year-over-year; the trailing twelve-month figure through Dec 2020 was $386.4 million (up 26.36% YoY), and the FY2020 annual result was $386.4 million, down 4.49% from the prior year.
• Gross Profit came in at $115.8 million for Q4 2020 at Ironwood Pharmaceuticals, up from $103.5 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $115.8 million in Q4 2020 to a low of -$21.3 million in Q4 2018.
• The 4-year median for Gross Profit is $77.4 million (2018), against an average of $71.8 million.
• Across the five-year window, Gross Profit sank 124.95% in 2018 and surged 642.2% in 2019, its largest moves.
• Ironwood Pharmaceuticals' Gross Profit stood at $85.2 million in 2017, then tumbled by 124.95% to -$21.3 million in 2018, then soared by 642.2% to $115.3 million in 2019, then advanced by 0.43% to $115.8 million in 2020.
• The last three Gross Profit figures came in at $115.8 million (Q4 2020), $103.5 million (Q3 2020), and $89.4 million (Q2 2020), per Business Quant data.